Clinical Study
Effectiveness of Dose Adjustment of Insulin in Type 2 Diabetes among Hemodialysis Patients with End-Stage Renal Disease: A Randomized Crossover Study
Table 1
Baseline characteristics of patients.
| | |
| Female (, %) | 37 (72.6) | Age (years) | | Mean arterial blood pressure (mmHg) | | Heart rate (/min) | | Comorbid diseases (, %) | | (i) Hypertension | 48 (94.1) | (ii) Cardiovascular diseases | 11(21.5) | Dialysis vintage (years) | | BUN (mg/dL) | | Serum creatinine (mg/dL) | | Serum albumin (g/dL) | | LDL-cholesterol (mg/dL) | | Single-pool | | Plasma glucose (mg/dL) | | Hemoglobin A1C (%) | | Plasma sodium (mEq/L) | | Plasma potassium (mEq/L) | | Plasma chloride (mEq/L) | | Plasma bicarbonate (mEq/L) | | Insulin types | | (i) Humulin premix | 43 (84.3) | (ii) Humulin N | 8 (15.7) | Antihypertensive agents (, %) | | (i) Calcium channel blockers | 22 (43.1) | (ii) Beta blockers | 18 (35.3) | (iii) Diuretics | 19 (37.3) | (iv) Alpha blockers | 6 (11.8) | (v) Renin angiotensin aldosterone blockers | 9 (17.7) | (vi) Others | 26 (50.9) |
|
|
Data is presented as mean with SD and percentage.
|